About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Houston | 516 Studies

Clinical Trials Prostate CancerHouston

Prostate Cancer Clinical Trials in Houston

Find 516 clinical trials for prostate cancer near Houston, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 461-480 of 516 trials

CompletedPhase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate CancerThe goal of this clinical research study is to find the highest safe dose of docetaxel in combination with Gleevec (imatinib mesylate) that can be given to men with advanced…NCT00038194·Houston, Texas RecruitingA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerThis study will test whether BNT324 is safe and works better against metastatic castration-resistant prostate cancer (mCRPC) than the current standard of care (SoC) chemotherapy…NCT07365995·Santa Barbara, California and 32 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingTreatment of Patients With Progressive mCRPC With 177Lu-PSMA-617The purpose of this study is to evaluate the safety and tolerability of Lutetium-177-PSMA-617 (PLUVICTO) in patients with metastatic castration-resistant prostate cancer (mCRPC)…NCT06972628·Houston, Texas

CompletedAmbulatory Cancer Pain Management: A Feasibility StudyThe primary purpose of this study is to examine the feasibility of collecting pain and other symptom data in outpatient treatment centers across multiple institutions in the Texas…NCT00507351·Houston, Texas and 3 others

RecruitingFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)Researchers are looking for a better way to treat participants who have metastatic castration-resistant prostate cancer (mCRPC). mCRPC is a cancer of the prostate (male…NCT06217822·Duarte, California and 34 others

Active not recruitingA Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)The purpose of this study is to learn whether adding abemaciclib to abiraterone plus prednisone prolongs the time before prostate cancer gets worse.NCT05288166·Prescott, Arizona and 265 others

TerminatedA Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess the safety, efficacy, tolerability, and toxicity of docetaxel alone, in combination with BMS-986218, or in combination with nivolumab plus…NCT05169684·Tucson, Arizona and 30 others

CompletedA Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to HistopathologyThis was a multicenter, multi-reader, open-label, Phase 2 study assessing the safety and performance characteristics of MIP 1404 imaging in the detection of prostate gland and…NCT01667536·Duarte, California and 34 others

TerminatedStudy of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.The purpose of this study is to assess the safety, tolerability and preliminary efficacy of CYH33 in combination with olaprib in patients with DDR gene mutations and/or PIK3CA…NCT04586335·New Haven, Connecticut and 6 others

RecruitingREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaThis study is researching a new drug called REGN15505 when used alone or in combination with cemiplimab or in combination with REGN4336 in adult patients with mCRPC and ccRCC.NCT07594106·Goodyear, Arizona and 5 others

TerminatedEffect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate CancerThe purpose of this study is to determine whether GTx 758 is effective in achieving and maintaining castrate testosterone levels in men with advanced prostate cancer.NCT01326312·Phoenix, Arizona and 35 others

Active not recruitingSafety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)The purpose of this study is to assess enzalutamide plus leuprolide in patients with high-risk nonmetastatic prostate cancer progressing after radical prostatectomy or…NCT02319837·Birmingham, Alabama and 254 others

RecruitingTesting Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerThis phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45…NCT05946213·Birmingham, Alabama and 412 others

RecruitingA Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerMedicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer.NCT04729114·Tucson, Arizona and 24 others

WithdrawnApalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate CancerThis study is open to men who have biochemical recurrence (BCR, increased PSA) following local treatment of their prostate cancer.NCT02811809·Houston, Texas

RecruitingPROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.1. Personalize treatment for prostate cancer based on how aggressive the disease is and 2.NCT06274047·Gilbert, Arizona and 5 others

CompletedStudy of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPCThe goal of this clinical research study is to learn if olaparib, when given after treatment with cabazitaxel, carboplatin, and prednisone, can help to control aggressive variant…NCT03263650·Houston, Texas

Active not recruitingAbiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate CancerThis phase II trial studies how well abiraterone acetate, prednisone, and apalutamide work in treating patients with hormone-naive prostate cancer that has spread to other places…NCT03821792·Houston, Texas

TerminatedApalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate CancerThis phase II trial studies how well apalutamide and abiraterone acetate work in treating participants with castration resistant prostate cancer that has spread to other places in…NCT03360721·Houston, Texas

UnknownEnd of Life Treatment Preferences of Latino Medicare Beneficiaries With CancerObjectives: The primary objective of the research project is to investigate how declining health status influences the end-of-life (EOL) treatment preferences in Latino Medicare…NCT01389830·Houston, Texas

PreviousPage 24 of 26Next

Other Conditions in Houston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma